Your browser is no longer supported. Please, upgrade your browser.
Settings
ACHV Achieve Life Sciences, Inc. daily Stock Chart
ACHV [NASD]
Achieve Life Sciences, Inc.
Index- P/E- EPS (ttm)-5.51 Insider Own4.97% Shs Outstand7.36M Perf Week-13.71%
Market Cap25.02M Forward P/E- EPS next Y-1.91 Insider Trans- Shs Float6.24M Perf Month-3.95%
Income-12.70M PEG- EPS next Q-0.88 Inst Own22.90% Short Float6.80% Perf Quarter95.40%
Sales- P/S- EPS this Y83.60% Inst Trans-18.04% Short Ratio0.25 Perf Half Y94.29%
Book/sh2.36 P/B1.44 EPS next Y11.50% ROA-80.10% Target Price12.00 Perf Year-70.18%
Cash/sh1.98 P/C1.71 EPS next 5Y- ROE-97.40% 52W Range1.04 - 14.31 Perf YTD180.99%
Dividend- P/FCF- EPS past 5Y56.70% ROI- 52W High-76.24% Beta2.93
Dividend %- Quick Ratio4.80 Sales past 5Y- Gross Margin- 52W Low225.39% ATR0.30
Employees13 Current Ratio4.80 Sales Q/Q- Oper. Margin- RSI (14)37.73 Volatility9.24% 8.21%
OptionableNo Debt/Eq0.00 EPS Q/Q82.80% Profit Margin- Rel Volume0.11 Prev Close3.49
ShortableYes LT Debt/Eq0.00 EarningsMay 15 AMC Payout- Avg Volume1.72M Price3.40
Recom- SMA20-17.82% SMA50-4.37% SMA20035.93% Volume192,676 Change-2.58%
May-15-19 04:05PM  Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
May-07-19 05:30AM  Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019 PR Newswire
Apr-26-19 10:00AM  ACHV: Final Enrollee, Final Visit Zacks Small Cap Research +8.21%
Apr-24-19 05:30AM  Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Apr-03-19 05:30AM  Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019 PR Newswire +5.64%
Apr-02-19 07:30AM  The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial Benzinga
05:30AM  Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Mar-25-19 10:00AM  ACHV: Fiscal Year 2018 Operational and Financial Results Zacks Small Cap Research +6.71%
Mar-18-19 08:35AM  What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline ACCESSWIRE +5.32%
05:30AM  Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-15-19 04:05PM  Four Healthcare Stocks Picking Up Speed On Friday ACCESSWIRE +22.86%
Mar-14-19 04:05PM  Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update PR Newswire
Mar-12-19 01:00PM  ACHV: A Reason to Quit is a Reason to Buy Zacks Small Cap Research
Mar-05-19 05:30AM  Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019 PR Newswire
Feb-28-19 09:00AM  Predictive Technology Group Names Jay M. Moyes to Its Board of Directors GlobeNewswire
Feb-25-19 10:30AM  Healthcare Stocks Leading the Sector ACCESSWIRE -19.70%
06:26AM  Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful? Simply Wall St.
Feb-22-19 10:40AM  Four Healthcare Stocks Looking to Close Out a Strong Week ACCESSWIRE +84.36%
08:36AM  Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial MarketWatch
05:30AM  Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting PR Newswire
Feb-20-19 05:30AM  Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation PR Newswire -9.20%
Dec-28-18 07:06AM  5 Top Rising P/E Stocks to Enjoy Solid Gains Zacks
Dec-18-18 05:30AM  Achieve Announces Update on Cytisinicline Clinical Development Program PR Newswire -5.93%
Nov-29-18 08:06AM  Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals Zacks -6.63%
Nov-28-18 07:04AM  5 Top-Ranked Rising P/E Stocks to Lure Investors Zacks
Nov-07-18 04:05PM  Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update PR Newswire
Oct-31-18 05:30AM  Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 PR Newswire
Oct-30-18 09:45AM  3 Healthcare Stocks that Could Move on Industry Growth ACCESSWIRE
05:30AM  Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation PR Newswire
Oct-03-18 12:41PM  Achieve Life Sciences Stock Will Probably Tumble Further InvestorPlace
Oct-01-18 09:05AM  Achieve Announces Pricing of $5.6 Million Registered Direct Offering PR Newswire -15.24%
Sep-27-18 08:56AM  Achieve Life Sciences' stock rockets on positive study results for smoking cessation drug MarketWatch +39.56%
05:30AM  Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects PR Newswire
Sep-26-18 05:30AM  Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 PR Newswire
Sep-18-18 05:30AM  Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy PR Newswire
Sep-06-18 05:30AM  Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference PR Newswire
Sep-05-18 05:30AM  Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018 PR Newswire
Aug-08-18 04:05PM  Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update PR Newswire
Aug-02-18 05:30AM  Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018 PR Newswire
Jul-12-18 08:00AM  Today's Research Reports on Stocks to Watch: Achieve Life Sciences and Pfizer ACCESSWIRE -9.25%
Jul-11-18 10:52AM  Achieve Life Sciences Shares Surge On Development Plan For Smoking Cessation Candidate Benzinga +10.50%
05:30AM  Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA PR Newswire
Jun-27-18 08:00AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Achieve Life Sciences ACCESSWIRE -19.80%
Jun-26-18 11:41AM  Achieve Life Sciences Shares Rip Higher On Positive Data For Smoking Cessation Drug Benzinga +34.21%
05:30AM  Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction PR Newswire
Jun-19-18 04:01PM  Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option PR Newswire
Jun-15-18 08:30AM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire -29.81%
Jun-11-18 05:30AM  Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules PR Newswire
May-25-18 06:09PM  Should You Be Concerned About Achieve Life Sciences Incs (NASDAQ:ACHV) Shareholders? Simply Wall St.
May-23-18 05:30AM  Achieve Life Sciences, Inc. Announces Reverse Stock Split PR Newswire -9.91%
May-09-18 04:15PM  Achieve Reports Financial Results for First Quarter 2018 PR Newswire
May-07-18 05:30AM  Achieve Announces Patent Granted on Novel Formulation of Cytisine PR Newswire
Mar-06-18 05:30AM  Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health PR Newswire +7.94%
Mar-01-18 04:30PM  Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results PR Newswire
04:30PM  Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results CNW Group
Feb-20-18 05:30AM  Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study PR Newswire +6.34%
05:30AM  Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study CNW Group
Feb-13-18 07:00AM  Innovative Cancer Immunotherapy Company, Novelogics Biotechnology, Inc. adds Scott D. Cormack to the Board of Directors to Expand Strategic Growth Plans CNW Group
Feb-02-18 12:30PM  A Day Trader's View On Why Bigger Is (Usually) Better Benzinga -5.30%
Jan-26-18 08:05AM  Achieve Life Sciences Making Progress in the Smoking Cessation Market, Recent Events ACCESSWIRE -5.82%
Jan-24-18 05:30AM  Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories PR Newswire +32.84%
05:30AM  Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories CNW Group
Jan-23-18 06:53PM  What Does Achieve Life Sciences Incs (NASDAQ:ACHV) Ownership Structure Look Like? Simply Wall St.
Jan-02-18 04:59PM  A Look At Achieve Life Sciences Inc (NASDAQ:ACHV) And The Healthcare Sector Simply Wall St. +7.20%
Nov-28-17 05:30AM  Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation PR Newswire
05:30AM  Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation CNW Group
Nov-14-17 05:30AM  Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects PR Newswire
05:30AM  Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects CNW Group
Nov-09-17 04:05PM  Achieve Reports Financial Results for Third Quarter 2017 PR Newswire
04:05PM  Achieve Reports Financial Results for Third Quarter 2017 CNW Group
Nov-08-17 05:30AM  Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017 PR Newswire +5.04%
05:30AM  Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017 CNW Group
Nov-06-17 08:31AM  Achieve Announces Availability of Company Presentation from the Virtual Investor Conference PR Newswire -13.04%
08:31AM  Achieve Announces Availability of Company Presentation from the Virtual Investor Conference CNW Group
Oct-30-17 10:41AM  Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd PR Newswire -12.56%
10:41AM  Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd CNW Group
08:31AM  Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017 PR Newswire
08:31AM  Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017 CNW Group
Oct-26-17 05:30AM  Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine CNW Group +15.34%
Oct-04-17 05:30AM  Achieve Announces Advancement of Cytisine Clinical Development Program PR Newswire
Sep-14-17 04:05PM  Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC PR Newswire
04:05PM  Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC CNW Group
Aug-16-17 06:00AM  Achieve Announces Initiation of Cytisine Clinical Development Program CNW Group -5.88%
Aug-10-17 04:30PM  Achieve Announces FDA Acceptance of the Investigational New Drug Application (IND) for Cytisine as a Smoking Cessation Treatment PR Newswire -14.41%
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has a license agreement with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.